pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,690 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06944795: SWIR Otoscopy Study

Sponsor: Stanford University. Phase: NA. Conditions: Otitis Media, Otitis Media Chronic, Otitis Media Effusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT03624595: Low-dose Dexmedetomidine and Postoperative Delirium After Cardiac Surgery

Sponsor: Dong-Xin Wang. Phase: NA. Conditions: Cardiac Surgery, Cardiopulmonary Bypass, Dexmedetomidine, Delirium, Survival

full page →ctgov ↗
›COMPLETEDphase readoutNCT02433795: Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Sponsor: Seoul National University Hospital. Phase: PHASE2. Conditions: Marginal Zone B-cell Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04408495: Intraoperative Mechanical Ventilation and Postoperative Pulmonary Complications After On-pump Cardiac Surgery in High-risk Patients

Sponsor: Rennes University Hospital. Phase: NA. Conditions: Postoperative Pulmonary Complications

full page →ctgov ↗
›TERMINATEDphase readoutNCT04990895: A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys

Sponsor: AHS Cancer Control Alberta. Phase: NA. Conditions: Colorectal Cancer, Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321639: Ultrasound-Guided Regional Blocks for Postoperative Analgesia After Laparoscopic Cholecystectomy

Sponsor: Istanbul Medipol University Hospital. Phase: NA. Conditions: Laparoscopic Cholecystectomy, Acute Pain, Pain Management, Plane Blocks

full page →ctgov ↗
›RECRUITINGphase readoutNCT07308639: DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Sponsor: Bayer. Phase: . Conditions: Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06639477: Assessing Improvements in Mood and Sleep Trial

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Depression, Suicidality, Sleep

full page →ctgov ↗
›COMPLETEDphase readoutNCT07011277: Gait Characteristics of Women With Breast Cancer-Related Lymphedema

Sponsor: Gazi University. Phase: . Conditions: Breast Cancer Related Lymphedema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06979375: A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

Sponsor: Novo Nordisk A/S. Phase: PHASE2. Conditions: Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT03403257: Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)

Sponsor: University of Michigan. Phase: . Conditions: Dementia, Dementia Alzheimers, Dementia, Vascular, Dementia, Mixed

full page →ctgov ↗
›COMPLETEDphase readoutNCT00339157: Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: PHASE2. Conditions: Systemic-Onset Juvenile Idiopathic Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06124157: A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: B Acute Lymphoblastic Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07619157: A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Type2 Diabetes Mellitus, Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07400601: A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital

Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Acute Myocardial Infarction (AMI)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06975501: Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity

Sponsor: Duke Kunshan University. Phase: NA. Conditions: Hypertension, Type 2 Diabetes Mellitus (T2DM), Multimorbidity, Stroke

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07443501: Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: CMV Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07600801: LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B

Sponsor: Massachusetts General Hospital. Phase: . Conditions: Family History of Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07058012: A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Sponsor: NSABP Foundation Inc. Phase: PHASE2. Conditions: Colo-rectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07334912: AEF0217 in Participants With Down Syndrome

Sponsor: Aelis Farma. Phase: PHASE2. Conditions: Down Syndrome (Trisomy 21)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05388812: Together in Recovery With Veterans Through Employment

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Veterans With Opioid Use Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498881: LasaiON is an Evidence-informed, Multimodal Self-regulation Program Designed to Reduce Emotional Distress and Strengthen Stress-regulation Skills by Combining Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Breathing Supported by Heart-rate Variability Biofeedback (HRV-B; emWave).

Sponsor: University of the Basque Country (UPV/EHU). Phase: NA. Conditions: Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT00448981: Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial

Sponsor: Centers for Disease Control and Prevention. Phase: NA. Conditions: Respiratory Tract Infections, Common Cold

full page →ctgov ↗
›COMPLETEDphase readoutNCT06961981: Remote Vinyasa Yoga Program for Heart Health

Sponsor: West Virginia University. Phase: NA. Conditions: Hypertension, Cardiovascular Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06802081: TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Sponsor: The Cleveland Clinic. Phase: PHASE2. Conditions: Atrial Fibrillation, Obesity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05430230: Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis

Sponsor: Northwestern University. Phase: PHASE4. Conditions: Osteoarthritis, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07568730: A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis

Sponsor: TearSolutions, Inc.. Phase: PHASE2. Conditions: Neurotrophic Keratitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07698028: ExMI vs. Biofeedback PFMT for Post-Prostatectomy Incontinence

Sponsor: Tanta University. Phase: NA. Conditions: Post-Prostatectomy Urinary Incontinence, Benign Prostatic Hyperplasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07447128: Prospective Analysis of Arteriovenous Access (AVA) Use in Continuous Renal Replacement Therapy: A Feasibility Project

Sponsor: East Carolina University. Phase: NA. Conditions: Continuous Renal Replacement Therapy (CRRT), End Stage Kidney Disease (ESRD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03847428: Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07294365: A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

Sponsor: Dizal Pharmaceuticals. Phase: PHASE2. Conditions: Immune Thrombocytopenia (ITP)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03304665: Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies

Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06906107: Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief

Sponsor: Baylor University. Phase: NA. Conditions: Neck Pain Musculoskeletal, Neck Pain Treatment, Cervicalgia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498907: Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma

Sponsor: Peking University First Hospital. Phase: PHASE2. Conditions: Upper Tract Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05987592: BE WELL With Migraine: Brain Education and WELLness With Migraine

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Migraine

full page →ctgov ↗
›WITHDRAWNphase readoutNCT03297892: Health Status of the Patients Followed for a Disease of Cushing in the Region Large-West of 1990 to 2015

Sponsor: University Hospital, Brest. Phase: . Conditions: Cushing Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06915792: PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy

Sponsor: University of California, Los Angeles. Phase: PHASE4. Conditions: Postpartum Hypertension (PPHT)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07317011: "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.

Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS. Phase: . Conditions: Hepatitis, Delta

full page →ctgov ↗
›COMPLETEDphase readoutNCT07318311: Comparative Evaluation of the Effect of pH Adjustment of the Solution of Articaine With Epinephrine on the Efficacy of Jet Anesthesia

Sponsor: Aristotle University Of Thessaloniki. Phase: NA. Conditions: Comparative Evaluation of the Effect of pH Adjustment of the Solution of Articaine With Epinephrine on the Efficacy of Jet Anesthesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT00160771: Biomechanics/Motion Analysis Laboratory Data Bank

Sponsor: University of Florida. Phase: . Conditions: Kinematics

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07215871: Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Influenza Infection, Infections, Respiratory Virus Infections, Respiratory Tract Infections, RNA Viruses, Orthomyxoviridae Infections, Viral Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07402109: CBCT Guided Markerless SBRT for Renal Cell Cancer

Sponsor: Erasmus Medical Center. Phase: NA. Conditions: Renal Cell Carcinoma (RCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07293364: A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema

Sponsor: Takeda. Phase: NA. Conditions: Hereditary Angioedema (HAE)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06575309: THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Pregnant Women, Venous Thromboembolic Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05549609: A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

Sponsor: Xintela AB. Phase: PHASE1. Conditions: Venous Leg Ulcer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05965609: Optimizing Sleep Health in Nurses

Sponsor: Oregon State University. Phase: NA. Conditions: Circadian Rhythm Sleep-Wake Disorders, Shift Work Type, Sleep Initiation and Maintenance Disorders

full page →ctgov ↗
›COMPLETEDphase readoutNCT04741009: Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing

Sponsor: Cochlear. Phase: NA. Conditions: Sensorineural Hearing Loss, Low-Frequency Residual Hearing

full page →ctgov ↗
›COMPLETEDphase readoutNCT07049809: Targeting Sarcopenia and Frailty: Multicomponent Exercise With Focal Muscle Vibration

Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Sarcopenia, Frailty at Older Adults, Cognitive Impairment, Adherence

full page →ctgov ↗
›RECRUITINGphase readoutNCT05147909: Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Physical Inactivity, Phosphate Overload, Visceral Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06039709: Sonodynamic Therapy in Patients With Recurrent GBM

Sponsor: Shayan Moosa, MD. Phase: PHASE1. Conditions: Recurrent Glioblastoma, Glioblastoma Multiforme, GBM

full page →ctgov ↗
← prev
page 113 of 114
next →